For Press
The Melanoma Research Alliance is the world's largest non-profit funder of melanoma research, the deadliest form of skin cancer. Founded in 2007 by Debra and Leon Black, MRA has invested over $160 million and leveraged an additional $450 million to support the best minds in science – from those investigating early detection to new treatments to scientists unraveling the complexities of rare melanoma and metastatic melanomas. MRA-funded researchers have been at the vanguard of every major breakthrough of melanoma prevention, detection, treatments and survivorship. Our approach accelerates the entire fields and moves closer to the answers we need.
With access to 200+ leading clinicians and scientists in the field and an in-house team of experts, the Melanoma Research Alliance is a trusted resource for members of the media to discuss the latest in melanoma research, skin health, dermatology advances and news.
We welcome members of the media to contact our Communications and Engagement team for more information:
Media Inquiries - Please Contact:
MRA Director, Communications and Engagement, Dana Deighton
ddeighton@curemelanoma.org
or
KWT Global
mra@kwtglobal.com
10/4/24 | Melanoma Research Alliance Names Sara DiNapoli as Director of Scientific Programs
6/6/24 | Melanoma Research Alliance Names Dana Deighton as Director of Communications and Engagement
5/1/24 | Melanoma Research Alliance Announces $12.6 Million Investment in Cutting Edge Melanoma Research
2/16/24 | Melanoma Research Alliance Applauds FDA Approval of First Cellular Therapy in Melanoma
10/13/23 | MRA Applauds Expanded Approval of Nivolumab to Patients with Stage 2 Disease
7/20/23 | Melanoma Research Alliance Announces 2023 Dermatology Fellowship Award Recipients
6/15/23 | Leveraged Finance Community Raises $3.1 Million for Innovative & Lifesaving Melanoma Research
5/01/23 | MRA Announces $6.3 Million in Grants to Advance Melanoma Prevention, Detection & Treatment
4/27/23 | Melanoma Research Alliance and Spot My UV Renew Partnership to Promote Sun Safety
5/11/22 | The Melanoma Research Alliance Names Dr. Marc Hurlbert as Chief Executive Officer
3/18/22 | MRA Statement on FDA Approval of Relatlimab + Nivolumab for Treatment of Advanced Melanoma
1/26/22 | MRA Statement on FDA Approval of Tebentafusp, the First Drug for Treating Metastatic Uveal Melanoma
12/6/21 | MRA Applauds Expanded Approval of Pembrolizumab to Patients with Stage 2 Melanoma
7/8/2021 | MRA Announces 13 Dermatology Fellowship Award Recipients
4/27/2021 | Melanoma Research Alliance Announces $8.1 million in Research Awards
10/8/2020 | Melanoma Research Alliance Announces 13 Dermatology Fellowship Awards
8/3/2020 | Melanoma Research Alliance Hails FDA’s First ‘Triplet’ Combination Approval for Melanoma
4/30/2020 | MRA Announces $11 Million in New Funding for 26 Grant Awards to Advance Melanoma Research
12/19/2019 | Leading Melanoma Organizations Applaud Congress for Supporting $20 million for Defense-Funded Melanoma Research
11/5/2019 | Melanoma Research Alliance Announces Almost $20 Million in New Funding to Support Melanoma Research Program
10/10/19 | Two New $1 Million Research Grants Focus on Metastasis of Melanoma
9/4/19 | Melanoma Research Alliance Announces Nine Research Awards in Inaugural Class of Dermatology Fellows
5/23/19 | Leveraged Finance Community Unites to Raise Awareness and Critical Funding for Melanoma Research
4/30/19 | MRA Announces $8.2 Million for 33 Grant Awards to Advance Melanoma Research
2/20/19 | Melanoma Research Alliance Welcomes FDA Approval of Pembrolizumab in Adjuvant Setting
10/4/18 | Melanoma Research Alliance Appoints Marc Hurlbert, Ph.D. Chief Science Officer
10/1/18 | Melanoma Research Alliance Applauds Advisory Panel Member Jim Allison for Nobel Prize in Medicine
8/7/18 | Melanoma Research Alliance Announces New Funding Opportunity for
Research to Accelerate Progress Toward Curing Melanoma
6/27/18 | MRA Applauds Latest Melanoma Drug Approval
5/24/18 | Leveraged Finance Industry Raises Record $2 million for Life-Saving Melanoma Research
5/10/18 | New Grants Totaling $2.6 Million Fund Work to Reduce Immunotherapy Side Effects
4/24/18 | Melanoma Research Alliance Announces $11.8 Million in 28 New Grants to Advance Melanoma Research
12/21/17 | MRA Applauds FDA Approval of Nivolumab to Reduce the Risk of Melanoma Returning After Surgery
12/5/2017 | Melanoma Research Alliance and Antidote Technologies Unveil Clinical Trial Locator, Giving Patients Better Access to Clinical Trials and Accelerating Research
11/15/2017 | Melanoma Research Alliance and Inspire Launch Online Community Focused on Research and Clinical Trials
6/30/2017 | American Cancer Society and Melanoma Research Alliance Partner to Improve Immunotherapy Outcomes
5/25/2017 | Leveraged Finance Industry Raises $1.8 million at Sixth Annual Melanoma Benefit
5/1/2017 | Leveraged Finance Industry to Gather at Sixth Annual Melanoma Benefit
4/27/2017 | Melanoma Research Alliance Announces More Than $8.5 million in New Grants for Melanoma Research
05/26/2016 | Senate Appropriations Committee Increases Military Cancer Research Funding to $60 Million
05/17/2016 | Patient advocate Michael Kaplan to lead Melanoma Research Alliance
05/03/2016 | Melanoma Research Alliance Announces Over $10.5 Million in New Research Awards
03/30/2016 | Immunotherapy and Melanoma Research Get Big Boost with Bloomberg-Kimmel Institute
01/20/2016 | MRA Provides Comments to FDA on Sunlamp Products
12/23/2015 | Melanoma Treatments Made Great Strides in 2015
11/10/2015 | Melanoma Research Alliance Applauds Latest Approved Combination Therapy
11/09/2015 | Melanoma Research Alliance Hosts Benefit Dinner at Sotheby’s to Raise Funds for Groundbreaking Melanoma Research
10/29/2015 | MRA Hails FDA Approval of Expanded Treatment for Melanoma
10/28/2015 | MRA Lauds FDA Approval of First Vaccine for Melanoma Treatment
10/01/2015 | MRA Hails FDA Approval of First Combination Immunotherapy for Melanoma
09/09/2015 | Melanoma Research Alliance Appoints Robin L. Davisson, Ph.D., President and CEO-Elect
09/08/2015 | MRA Applauds James Allison for Prestigious Lasker Award
08/27/2015 | MRA Applauds Latest Drug Approval Abroad
08/17/2015 | Melanoma Research Alliance Elects Mary Jo Rogers to Board of Directors
06/23/2015 | Melanoma Research Alliance Announces More Than $13 million in New Grants for Melanoma Research
06/17/2015 | Senate Appropriations Committee Approves $50 Million for Military Cancer Research
06/03/2015 | 2015 ASCO Meeting Highlights Impact of Melanoma Research On Field of Oncology
05/04/2015 | MRA Teams with L’Oréal Paris for It’s THAT Worth It™ Public Health Campaign & Social Media Call to Action
04/24/2015 | 2015 AACR Annual Meeting Highlights Developments in Melanoma Research
04/07/2015 | Leveraged Finance Industry to Gather to Fight Melanoma
02/09/2015 | MELANOMA RESEARCH ALLIANCE REPORTS WENDY SELIG TO STEP DOWN AS PRESIDENT AND CEO
01/30/2015 | MRA Applauds President Obama's Precision Medicine Initiative
01/13/2015 | MRA Lauds Chair of Scientific Advisory Panel for Peer Recognition
12/22/2014 | MRA Applauds Latest Melanoma Drug Approval
12/11/2014 | MRA-MRF Urge Congress to Approve Funding for Melanoma Research
12/10/2014 | Final Budget Bill Doubles DoD Funding Available for Melanoma Research
12/03/2014 | NCI FY 2016 Budget Plan Highlights Critical Opportunities
11/17/2014 | Society of Melanoma Research International Congress
11/13/2014 | MRA Applauds Congress for Getting the Sunscreen Innovation Act over the Goal Line
09/26/2014 | AACR Conference Showcases Developments in Melanoma
09/17/2014 | MRA Applauds Senate Passage of the Sunscreen Innovation Act
09/12/2014 | MRA Letter of Support to Senate on the Sunscreen Innovation Act
09/04/2014 | MRA Applauds Latest Drug Approval as Major Breakthrough
09/02/2014 | MRA Announces 2014-2015 Request For Proposals
08/29/2014 | MRA Comments to Senate HELP Committee on the Sunscreen Innovation Act
07/28/2014 | MRA Applauds Speedy Passage of Sunscreen Innovation Act
07/21/2014 | (Video) Watch Melanoma Expert Dr. Jedd Wolchok Talk about PD-1 Clinical Trials
07/11/2014 | MRA Hails Launch of Expanded Access Program in Advanced Melanoma
TEST
07/07/2014 | MRA Applauds Hawaii for Becoming 10th State to Ban Indoor Tanning for Minors
06/16/2014 | MRA Ranked #1 Grant-Giving Disease Foundation by GEN
06/03/2014 | ASCO Annual Meeting Features Developments in Melanoma Research and Immunotherapies
05/29/2014 | MRA Applauds Louisiana for Becoming 9th State to Ban Indoor Tanning for Minors
05/29/2014 | MRA Applauds FDA's Reclassification of Tanning Devices
05/27/2014 | MRA Welcomes Distinguished Physician-Scientist Suzanne L. Topalian, M.D., to its Board of Directors
05/27/2014 | MRA Applauds Minnesota for Becoming 8th State to Ban Indoor Tanning for Minors
05/22/2014 | MRA Applauds Launch of Expanded Access Program in Advanced Melanoma
04/16/2014 | AMERICAN IDOL® LIVE! 2014 TOUR Supports the Melanoma Research Alliance
12/03/2013 | Melanoma Research Alliance and the Hidary Foundation Fund Research Study of Melanoma Genomics
11/22/2013 | New Research Progress Highlighted at the SMR Annual Congress Meeting
11/15/2013 | Melanoma Research Alliance Holds Record-Breaking Benefit Dinner at Sotheby’s New York
10/21/2013 | MRA Welcomes Two New Board Members-Cindy Hensley McCain and Dr. Elliott Sigal
08/16/2013 | MRA Commends Illinois on New Tanning Bed Restrictions for Minors
08/12/2013 | MRA Releases 2013-2014 Request For Proposals
08/08/2013 | MRA Applauds CDC, Office of the Surgeon General for Focusing on Skin Cancer Prevention
08/02/2013 | Senate Recommends Increased Funding for Medical Research
08/02/2013 | MRA Letter to FDA Supporting Reclassification of Tanning Devices
06/26/2013 | MRA Rings Closing Bell at New York Stock Exchange (NYSE)
06/18/2013 | Texas Becomes Fifth State to Enact New Tanning Bed Restrictions
06/06/2013 | MRA Applauds Nevada on New Tanning Bed Restrictions
06/04/2013 | MRA Statement on Melanoma Developments at the ASCO 2013 Annual Meeting
05/29/2013 | MRA Statement on FDA Approval of Two Genetically-Targeted Melanoma Therapies and Companion Diagnostic
05/22/2013 | MRA Applauds Oregon on New Tanning Bed Restrictions
05/13/2013 | Leveraged Finance Community Unites to Support Melanoma Research Alliance
05/06/2013 | MRA Statement on FDA's Proposed Reclassification of Tanning Devices
04/18/2013 | AMERICAN IDOL® LIVE! 2013 TOUR PARTNERS WITH MELANOMA RESEARCH ALLIANCE
04/15/2013 | Melanoma Research Alliance awards $9.6 million in research grants
04/11/2013 | Giada De Laurentiis Appears in New PSA For the Melanoma Research Alliance and Stand Up To Cancer
04/10/2013 | Melanoma Developments Highlighted at 2013 AACR Annual Meeting
01/29/2013 | MRA Names Louise M. Perkins, Ph.D., as First Full-time Chief Science Officer
12/18/2012 | New Cancer Immunology Dream Team Announced
09/27/2012 | Stand Up To Cancer and the Melanoma Research Alliance collaborate on PSA starring Laura Linney
09/26/2012 | MRA's letter to support Life-Threatening Diseases Compassion Through Combination Therapy Act of 2012
09/21/2012 | MRA Welcomes MD Anderson’s “Moon Shots” Program Effort
09/11/2012 | The Melanoma Research Alliance featured in Stand Up To Cancer Telecast
07/06/2012 | MRA releases comments on USPSTF Transparency and Accountability Act of 2012
06/20/2012 | Dermascope: The Science of Prevention by MRA's Laura Brockway-Lunardi
06/04/2012 | MRA-Funded Studies Take Center Stage in Fight against Deadly Skin Cancer at ASCO
05/17/2012 | A preview of melanoma discoveries to come at ASCO 2012
05/14/2012 | MRA's Letter to Congressman Bilbray in support of establishing a skin cancer fund at NIH
05/08/2012 | MRA releases statement on Federal Task Force recommendations on preventing skin cancer
04/24/2012 | MRA awards $4.9 million in research grants to investigators at 22 labs
04/05/2012 | MRA Releases Statement on the Mayo Clinic's Study Concerning the Increasing Incidence of Melanoma
04/04/2012 | Progress in melanoma highlighted at 2012 AACR meeting
02/01/2012 | MRA releases statement on new report about the dangers of tanning beds
12/15/2011 | Statement from MRA's Wendy Selig about Innovative Dream Team
12/14/2011 | MRA and SU2C announce Melanoma Dream Team Award
10/10/2011 | MRA Congratulates California on New Tanning Bed Restrictions
09/20/2011 | Wendy Selig comments on release of AACR Cancer Progress Report 2011
08/17/2011 | MRA Applauds Today's FDA Approval of Breakthrough New Treatment for Fighting Melanoma
07/25/2011 | MRA Corporate Allies Step Up Efforts in May
07/12/2011 | MRA Awards $5.6 Million in Research Grants
06/15/2011 | MRA Welcomes FDA Regulations on Sunscreen Products
06/12/2011 | MRA Remembers Courage of Laura Ziskin
06/06/2011 | MRA Welcomes Latest Advances in Melanomaand Research Findings Revealed at ASCO Annual Meeting
03/25/2011 | Melanoma Research Alliance Welcomes Approval of Ipilimumab to Treat Melanoma
11/11/2010 | MRA Salutes Progress in Melanoma Research
11/01/2010 | Melanoma Research Alliance Raises $5 Million at First Annual Benefit Dinner